Caption Management’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,200
| Closed | -$2.28K | – | 448 |
|
|
2024
Q2 | $2.28K | Buy |
+1,200
| New | +$2.28K | ﹤0.01% | 384 |
|
|
2024
Q1 | – | Sell |
-47,000
| Closed | -$692K | – | 401 |
|
|
2023
Q4 | $692K | Sell |
47,000
-42,256
| -47% | -$622K | 0.01% | 183 |
|
|
2023
Q3 | $1.63M | Buy |
89,256
+52,256
| +141% | +$957K | 0.03% | 104 |
|
|
2023
Q2 | $798K | Buy |
+37,000
| New | +$798K | 0.01% | 148 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 362 |
|
|
2022
Q4 | – | Sell |
-42,947
| Closed | -$1.21M | – | 439 |
|
|
2022
Q3 | $1.21M | Sell |
42,947
-26,704
| -38% | -$752K | 0.02% | 104 |
|
|
2022
Q2 | $1.34M | Buy |
69,651
+32,984
| +90% | +$635K | 0.02% | 151 |
|
|
2022
Q1 | $472K | Buy |
+36,667
| New | +$472K | 0.01% | 329 |
|